As of mid-August 2026, CDC data show 2,566 confirmed measles cases in the U.S., already exceeding the 2025 total of 2,289 and marking the highest annual count in 35 years, driven primarily by persistent outbreaks in under-vaccinated communities with 94% of cases linked to transmission chains spanning 2025–2026. Low MMR immunization rates, especially among children under 19 who comprise most infections, sustain high contagiousness via airborne spread, while imported cases seed new clusters. Trader sentiment reflects uncertainty over whether case counts will stabilize or accelerate through fall, with CDC surveillance reports released weekly offering the key data releases that could shift market-implied odds on the final 2026 tally. Historical patterns indicate outbreaks often peak in late summer before waning.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourCas de rougeole aux États-Unis en 2026 ?
Cas de rougeole aux États-Unis en 2026 ?
$7,831,348 Vol.
$7,831,348 Vol.
31 déc. 2026
↑4,5k
42%
↑3k
95%
↑3,5k
92%
↑4k
75%
↑5k
26%
↑7,5k
12%
↑10k
6%
↑12,5k
5%
$7,831,348 Vol.
$7,831,348 Vol.
31 déc. 2026
↑4,5k
$20 Vol.
42%
↑3k
$90,114 Vol.
95%
↑3,5k
$13,530 Vol.
92%
↑4k
$220,949 Vol.
75%
↑5k
$230,428 Vol.
26%
↑7,5k
$185,031 Vol.
12%
↑10k
$6,515,593 Vol.
6%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC data show 2,566 confirmed measles cases in the U.S., already exceeding the 2025 total of 2,289 and marking the highest annual count in 35 years, driven primarily by persistent outbreaks in under-vaccinated communities with 94% of cases linked to transmission chains spanning 2025–2026. Low MMR immunization rates, especially among children under 19 who comprise most infections, sustain high contagiousness via airborne spread, while imported cases seed new clusters. Trader sentiment reflects uncertainty over whether case counts will stabilize or accelerate through fall, with CDC surveillance reports released weekly offering the key data releases that could shift market-implied odds on the final 2026 tally. Historical patterns indicate outbreaks often peak in late summer before waning.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Marché ouvert : Feb 16, 2026, 11:51 AM ET
Volume
$7,831,348Date de fin
31 déc. 2026Marché ouvert
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of mid-August 2026, CDC data show 2,566 confirmed measles cases in the U.S., already exceeding the 2025 total of 2,289 and marking the highest annual count in 35 years, driven primarily by persistent outbreaks in under-vaccinated communities with 94% of cases linked to transmission chains spanning 2025–2026. Low MMR immunization rates, especially among children under 19 who comprise most infections, sustain high contagiousness via airborne spread, while imported cases seed new clusters. Trader sentiment reflects uncertainty over whether case counts will stabilize or accelerate through fall, with CDC surveillance reports released weekly offering the key data releases that could shift market-implied odds on the final 2026 tally. Historical patterns indicate outbreaks often peak in late summer before waning.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,831,348Date de fin
31 déc. 2026Marché ouvert
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of mid-August 2026, CDC data show 2,566 confirmed measles cases in the U.S., already exceeding the 2025 total of 2,289 and marking the highest annual count in 35 years, driven primarily by persistent outbreaks in under-vaccinated communities with 94% of cases linked to transmission chains spanning 2025–2026. Low MMR immunization rates, especially among children under 19 who comprise most infections, sustain high contagiousness via airborne spread, while imported cases seed new clusters. Trader sentiment reflects uncertainty over whether case counts will stabilize or accelerate through fall, with CDC surveillance reports released weekly offering the key data releases that could shift market-implied odds on the final 2026 tally. Historical patterns indicate outbreaks often peak in late summer before waning.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes